<SEC-DOCUMENT>0000313143-21-000003.txt : 20210120
<SEC-HEADER>0000313143-21-000003.hdr.sgml : 20210120
<ACCEPTANCE-DATETIME>20210120064715
ACCESSION NUMBER:		0000313143-21-000003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210117
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210120
DATE AS OF CHANGE:		20210120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HAEMONETICS CORP
		CENTRAL INDEX KEY:			0000313143
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042882273
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0403

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14041
		FILM NUMBER:		21537381

	BUSINESS ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		7818487100

	MAIL ADDRESS:	
		STREET 1:		125 SUMMER STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hae-20210117.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:2bd60b44-e22c-488a-9acc-c74c501c2c1c,g:14cc478b-025a-4caf-ac39-7318b3d68e67,d:4bf519a20b3749e18a61e620bfe0b31a--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hae-20210117</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV80L2ZyYWc6YjZjODBkYmYyY2UyNGEwM2FiYTAxZGY5YzQ3MzBiNTQvdGFibGU6MTBlZTI5YzkxMGJhNDkzN2I1NDBmOGYzZTdiMTIyMDYvdGFibGVyYW5nZToxMGVlMjljOTEwYmE0OTM3YjU0MGY4ZjNlN2IxMjIwNl8wLTEtMS0xLTA_d5cd048c-e72b-4da7-97b1-bc1bb2b75a10">0000313143</ix:nonNumeric><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV80L2ZyYWc6YjZjODBkYmYyY2UyNGEwM2FiYTAxZGY5YzQ3MzBiNTQvdGFibGU6MTBlZTI5YzkxMGJhNDkzN2I1NDBmOGYzZTdiMTIyMDYvdGFibGVyYW5nZToxMGVlMjljOTEwYmE0OTM3YjU0MGY4ZjNlN2IxMjIwNl8xLTEtMS0xLTA_861a835f-7ff6-4b6b-8257-abda3fd139ba">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hae-20210117.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000313143</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-17</xbrli:startDate><xbrli:endDate>2021-01-17</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i4bf519a20b3749e18a61e620bfe0b31a_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV84Mg_8d12ec27-0bf1-406b-baa2-df61b140cc3a">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 OR 15(d)&#160;of The Securities Exchange Act of 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV8yMjM_6c05c55d-f5ad-4a85-866e-d27c3caa92c7">January 17, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV8yMjg_7fd70d14-e7e5-4d5e-b555-56cb058dfe04">HAEMONETICS CORPORATION</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGEyYzJhNzIyOTA4NDQ4MjkxYzFmNDVhMDVmZTM3ZDAvdGFibGVyYW5nZTo0YTJjMmE3MjI5MDg0NDgyOTFjMWY0NWEwNWZlMzdkMF8wLTAtMS0xLTA_6ee89859-1051-4a37-b92c-f5dcd6db6da3">Massachusetts</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGEyYzJhNzIyOTA4NDQ4MjkxYzFmNDVhMDVmZTM3ZDAvdGFibGVyYW5nZTo0YTJjMmE3MjI5MDg0NDgyOTFjMWY0NWEwNWZlMzdkMF8wLTItMS0xLTA_0a1f1430-0f1c-4332-96c7-4efc231451a3">001-14041</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGEyYzJhNzIyOTA4NDQ4MjkxYzFmNDVhMDVmZTM3ZDAvdGFibGVyYW5nZTo0YTJjMmE3MjI5MDg0NDgyOTFjMWY0NWEwNWZlMzdkMF8wLTQtMS0xLTA_d1d53ae7-9a5a-4d23-91c8-fdcc61849c00">04-2882273</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="margin-bottom:2pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80OTU_5a8de55a-4660-4f97-8c26-179b70d120d6">125 Summer Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80OTY_333fd1f7-ac37-47b4-bc0d-8ea968ffb7a0">Boston</ix:nonNumeric>, <ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV8yOTc_81874397-db6d-4419-910b-beb096747c20">MA</ix:nonNumeric> <ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80OTc_e951c5bd-33c6-47e7-a69e-f315e1233605">02110</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80MTc_c83a7d29-e737-4ea6-959d-e694a2394850">781</ix:nonNumeric>-<ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80MjA_94825f80-8297-4571-8875-f1da2c41da19">848-7100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.005%"><tr><td style="width:1.0%"></td><td style="width:2.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl8yLTAtMS0xLTA_3524b0ee-ba1f-4bfb-a6e1-0d746613d8ef">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl8zLTAtMS0xLTA_36baf976-b15a-46ea-a459-054dcd559f0e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl80LTAtMS0xLTA_68553083-f71d-4678-85a4-7efe53596271">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl81LTAtMS0xLTA_df30a7f5-cdb1-4fee-a1a7-497a6869351c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.298%"><tr><td style="width:1.0%"></td><td style="width:38.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.659%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGMxMTRiNWU0NGFmNDRlYjk0ODc3NzcyMjZhNDk1MWMvdGFibGVyYW5nZTo0YzExNGI1ZTQ0YWY0NGViOTQ4Nzc3NzIyNmE0OTUxY18zLTAtMS0xLTA_8732faed-0162-4e81-9ea5-9f9425054c6a">Common stock, $.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGMxMTRiNWU0NGFmNDRlYjk0ODc3NzcyMjZhNDk1MWMvdGFibGVyYW5nZTo0YzExNGI1ZTQ0YWY0NGViOTQ4Nzc3NzIyNmE0OTUxY18zLTEtMS0xLTA_88916f81-1ac1-4f64-b1a0-3a57f3cdaf2e">HAE</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGMxMTRiNWU0NGFmNDRlYjk0ODc3NzcyMjZhNDk1MWMvdGFibGVyYW5nZTo0YzExNGI1ZTQ0YWY0NGViOTQ4Nzc3NzIyNmE0OTUxY18zLTItMS0xLTA_5a191d93-6e8c-4153-86f1-2204328b30d7">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Emerging Growth Company</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6M2MwZTRmYTZiNzc1NDRkYjkxMmQyODBhNTE5ZTc2MWMvdGFibGVyYW5nZTozYzBlNGZhNmI3NzU0NGRiOTEyZDI4MGE1MTllNzYxY18yLTAtMS0xLTA_5058df4c-a034-4bf1-ad7f-ffcf1014c329">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i4bf519a20b3749e18a61e620bfe0b31a_7"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 1.01  Entry into a Material Definitive Agreement.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On January 17, 2021, Haemonetics Corporation (the &#8220;Company&#8221;) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with Cardiva Medical, Inc., a Delaware corporation (&#8220;Cardiva&#8221;), Concordia Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company (&#8220;Merger Sub&#8221;), and Fortis Advisors LLC, a Delaware limited liability company, as the Seller&#8217;s Representative, pursuant to which Merger Sub will merge with and into Cardiva, with Cardiva surviving as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;). The Company will pay upfront consideration of $475 million in cash, subject to customary working capital and certain other adjustments as of the closing of the Merger (the &#8220;Closing&#8221;), as well as up to an additional $35 million in contingent consideration payable over the next two years based on sales growth.  </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Merger Agreement provides that, subject to the terms and conditions set forth therein, at the effective time of the Merger, unless otherwise specified in the Merger Agreement, all of the shares of common stock and preferred stock of Cardiva issued and outstanding immediately prior to the effective time of the Merger (other than certain stock owned by the Company or Cardiva and certain dissenting shares, if any) will no longer be outstanding and will automatically be cancelled and will be retired and cease to exist, and each holder thereof will cease to have any rights with respect thereto, except the right to receive the applicable consideration calculated as set forth in the Merger Agreement.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition, each in-the-money option to purchase shares of common stock of Cardiva that is outstanding (whether vested or unvested) immediately prior to the Closing will automatically be cancelled and only entitle the holder of such option to receive an amount of cash calculated as set forth in the Merger Agreement, without interest. Each warrant that is outstanding immediately prior to the Closing will automatically be cancelled and each holder thereof will be entitled to receive an amount of cash calculated as set forth in the Merger Agreement, without interest. In addition, certain of Cardiva&#8217;s employees will be entitled to change in control bonus payments under Cardiva&#8217;s employee retention plan provided that such employee remains employed by Cardiva immediately prior to the Closing.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Merger Agreement contains representations, warranties and covenants by the parties customary for a transaction of this nature, including covenants with respect to cooperation, regulatory approvals, the conduct and operation of Cardiva prior to the closing (including Cardiva&#8217;s agreement not to solicit alternative transactions or enter into discussions concerning, or provide confidential information in connection with, an alternative transaction) and similar matters. Other than in the case of fraud, Cardiva will have no obligation to indemnify the Company under the Merger Agreement for breaches of representations or warranties with respect to Cardiva, and the Company&#8217;s recourse for any such breaches will be limited to a representations and warranties insurance policy to be purchased by the Company prior to the Closing.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On January 17, 2021, following execution of the Merger Agreement, Cardiva delivered the written consent of a majority of each of the common stock and preferred stock holders of Cardiva, voting on an as converted basis,  approving and authorizing the Merger pursuant to the Merger Agreement, which is sufficient to satisfy the stockholder vote requirement for the Merger under applicable law and Cardiva&#8217;s charter documents.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The transaction is not subject to a financing contingency, and the Company expects to finance the transaction through a combination of its cash on hand, revolving credit facility and an additional $150 million term loan under its existing credit facility. The Merger Agreement also contains certain termination rights, including, among others, the right of either party to terminate the Merger Agreement if the Merger has not occurred by April 17, 2021 and the failure to consummate is not caused by a breach of the Merger Agreement by the terminating party.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Merger is expected to close in the first quarter of calendar 2021 and is subject to the satisfaction or waiver of certain customary mutual closing conditions. The Merger Agreement and the Merger have been unanimously approved by the boards of directors of the Company and Cardiva.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing description of the Merger Agreement and the transactions contemplated thereby does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which will be filed with the Company&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended December 26, 2020. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The above description of the Merger Agreement is not intended to provide any other factual information about the Company, Cardiva, or their respective subsidiaries or affiliates. The representations, warranties and covenants contained in the Merger Agreement were made only for purposes of the Merger Agreement and only as of specific dates, were solely for the benefit of the parties to the Merger Agreement, and may be subject to limitations agreed upon by the parties in connection with negotiating the terms of the Merger Agreement, including being qualified by confidential disclosures made by each party to the other for the purposes of allocating contractual risk between them. In addition, certain representations and warranties may be subject to a contractual standard of materiality different from those generally applicable to investors and may have been used for the purpose of allocating risk between the parties rather than establishing matters as facts. Information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in public disclosures by the Company or Cardiva. Investors should not rely on the representations, warranties or covenants or any description thereof as characterizations of the actual state of facts or condition of the Company, Cardiva or any of their respective subsidiaries, affiliates or businesses.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 7.01  Regulation FD Disclosure.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On January 20, 2021, the Company issued a press release announcing its entry into the Merger Agreement and that the Company will hold a conference call with financial analysts and investors at 8:00 a.m. Eastern Time on January 20, 2021 to discuss the announcement of the Merger Agreement and answer questions.  A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information furnished in this Item 7.01 shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of such section, nor shall such information be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">This Current Report on Form 8-K contains forward-looking statements about the Merger Agreement and the Merger, including, but not limited to, statements related to the timing of completion of the Merger and the consummation of the Merger, the anticipated financing of the Merger and other statements that are not historical facts. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company&#8217;s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that the Merger may not be completed in a timely manner or at all due to, among other factors, failure to receive required regulatory approvals or satisfy other closing conditions, and the risk that using debt to finance, in part, the Merger will substantially increase the Company&#8217;s indebtedness. Investors should consult the Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">s filings with the Securities and Exchange Commission (including the Company&#8217;s reports on Forms 10-K, 10-Q and 8-K) for information about additional risks and uncertainties that could cause the Company&#8217;s actual results to differ materially from these forward-looking statements. The Company undertakes no duty or obligation to update any forward-looking statements contained in this Current Report on Form 8-K as a result of new information, future events or changes in its expectations.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item 9.01  Financial Statements and Exhibits.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.289%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.135%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991pressrelease12021.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Press Release issued by Haemonetics Corporation on January 20, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="i4bf519a20b3749e18a61e620bfe0b31a_10"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:26.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.852%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.713%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HAEMONETICS CORPORATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">January 20, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/ Christopher A. Simon </span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Christopher A. Simon</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991pressrelease12021.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i43af29563c87434caa02664797a9cfd6_1"></div><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 99.1</font></div><div><font><br></font></div><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:25px;margin-bottom:5pt;vertical-align:text-bottom;width:288px"></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:42.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Olga Guyette, Director-Investor Relations</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(781) 356-9763</font></div><div><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">olga.guyette&#64;haemonetics.com </font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.5pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Media Contact&#58;</font></div><div style="padding-left:3.5pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Carla Burigatto, Vice President-Communications</font></div><div style="padding-left:3.5pt;text-indent:-0.01pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%">(781) 348-7263</font></div><div style="padding-left:3.5pt;text-indent:-0.01pt"><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:139%;text-decoration:underline">carla.burigatto&#64;haemonetics.com</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:139%">HAEMONETICS TO ACQUIRE CARDIVA MEDICAL, INC. TO EXPAND HOSPITAL PORTFOLIO </font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Enhances penetration into the large and growing interventional cardiology and electrophysiology markets</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Offers products with demonstrated and differentiated clinical benefits</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Expected to be accretive to revenue growth, gross margins and adjusted gross margins while providing attractive financial returns</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:14.15pt">Purchase price of up to $510 million cash</font></div><div style="padding-left:18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">BOSTON, MA, January 20, 2021 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">- Haemonetics Corporation (NYSE&#58; HAE) (&#8220;Haemonetics&#8221;), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., (&#8220;Cardiva&#8221;) an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Under the terms of the agreement, Haemonetics will acquire Cardiva for an upfront cash payment of $475 million at closing and up to an additional $35 million in contingent consideration based on sales growth. The acquisition is subject to customary closing conditions and is expected to be completed in the first quarter of calendar 2021. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Cardiva&#8217;s portfolio includes two catheter-based vascular access site closure devices. The VASCADE&#174; vascular closure system is designed for &#8220;small-bore</font><font style="color:#1f497d;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures, and is the only marketed closure device to significantly reduce access site complications versus manual compression. The VASCADE MVP&#174; vascular closure system is designed for &#8220;mid-bore</font><font style="color:#1f497d;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> multi-access femoral venous closure, generally used in electrophysiology procedures, and is the only FDA approved closure device for use following cardiac ablation procedures requiring two or more access sites within the same vessel. Both devices include Cardiva&#8217;s proprietary collapsible disc technology and a resorbable collagen patch to achieve hemostasis. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Chris Simon, Haemonetics&#8217; President and CEO, said, &#8220;We are excited to add Cardiva&#8217;s vascular closure technology to our portfolio and look forward to welcoming their talented team. This acquisition </font></div><div style="height:28.35pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">immediately expands and diversifies our hospital offerings in the large and growing interventional cardiology and electrophysiology markets and aligns with our innovation agenda.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">John Russell, Cardiva&#8217;s President and CEO, added, &#8220;We are delighted to become part of a company that shares our commitment to technology leadership and meaningfully advancing patient care in some of the most critical areas of medicine. We believe that Haemonetics&#8217; history of leadership in hemostasis management makes the Company an ideal partner to realize the full potential of our VASCADE platform technology.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The acquisition is expected to deliver about $65-$75 million of revenue in the first fiscal year. The transaction is expected to be dilutive to adjusted net earnings per diluted share by ($0.15 - $0.20) in fiscal year 2022 and about neutral to adjusted net earnings per diluted share in fiscal year 2023. The acquisition is expected to deliver a rate of return on invested capital of 10% by year five.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Haemonetics plans to finance this acquisition through a combination of cash, existing revolving credit facility and an additional $150 million term loan. Following this acquisition, the Company debt to EBITDA ratio, as calculated in accordance with the terms set forth in the Company&#8217;s existing Credit Agreement, is expected to be approximately 3.2.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">In connection with this transaction, Moelis &#38; Company LLC is serving as financial advisor to Haemonetics and DLA Piper is serving as legal advisor. Additionally, J.P. Morgan Securities LLC is acting as financial advisor to Cardiva and Cooley LLP is serving as legal advisor.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Conference Call and Webcast Information</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Haemonetics will host a conference call and webcast to discuss additional details regarding the proposed transaction on January 20 at 8&#58;00AM ET. The dial-in numbers for the conference call are (877) 848-8880 (domestic) or (716) 335-9512 (international). Conference ID number is 5838449. </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The conference call and webcast can also be accessed via the following link&#58; </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">https&#58;&#47;&#47;edge.media-server.com&#47;mmc&#47;p&#47;gumu3nq4 </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">A replay of the conference will be available from January 20, 2021 11&#58;00AM ET for one year using the link above.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">About Haemonetics </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Haemonetics (NYSE&#58; HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets&#58; blood and plasma component </font></div><div style="height:28.35pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">www.haemonetics.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">About Cardiva Medical, Inc.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Cardiva Medical, Inc. is a privately held medical device company focused on transforming vascular closure for the benefit of patients, hospitals and physicians in the over 5.5 million catheter-based coronary, peripheral and electrophysiology procedures in the United States that require access site closure each year.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The Company&#8217;s VASCADE&#174; vascular closure system has been PMA-approved by the FDA since 2013 and is indicated for vessel closure following 5-7F arterial and venous procedures. VASCADE&#174; is the only marketed closure system to demonstrate a statistically significant reduction in access site complications compared to the existing standard of care in a prospective, randomized, controlled clinical trial called RESPECT.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The latest product in the Company&#8217;s portfolio is VASCADE MVP&#174; Venous Vascular Closure System, the only marketed vessel closure technology designed specifically for Electrophysiology procedures &#8211; and clinically proven by Electrophysiology physicians in a multi-center, randomized, controlled clinical trial called AMBULATE. VASCADE MVP&#174; received PMA approval in late 2018.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Cardiva has won numerous recent awards for clinical, commercial and operational excellence &#8211; including the Shingo Bronze Medallion. The Company is headquartered in Santa Clara, California.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">To learn more about Cardiva Medical, visit </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">www.cardivamedical.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Cautionary Note Regarding Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements in this press release may include, without limitation, plans and objectives of management for the operation of Haemonetics, statements regarding the timing of completion of the acquisition and the consummation of the acquisition, the anticipated financing of the transaction, the anticipated benefits to Haemonetics arising from the completion of the acquisition, the impact of the acquisition on Haemonetics&#8217; business strategy and future business and operational performance, and the assumptions underlying or relating to any such statement. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon Haemonetics&#8217; current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ </font></div><div style="height:28.35pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:40.5pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">materially from expected or desired results may include, without limitation, the failure to realize the anticipated benefits of the acquisition or the acquisition, its announcement or pendency having an unanticipated impact, Haemonetics&#8217; ability to predict accurately the demand for products and products under development by it and Cardiva and to develop strategies to successfully address relevant markets, the impact of competitive products and pricing, technical innovations that could render products marketed or under development by Haemonetics or Cardiva obsolete, risks related to the use and protection of intellectual property, the risk that the transaction may not be completed in a timely manner or at all, and the risk that using debt to finance, in part, the acquisition will substantially increase Haemonetics&#8217; indebtedness. These and other factors are identified and described in more detail in Haemonetics&#8217; filings with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). Haemonetics does not undertake to update these forward-looking statements.</font></div><div><font><br></font></div><div style="height:28.35pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i43af29563c87434caa02664797a9cfd6_10"></div><hr style="page-break-after:always"><div style="min-height:28.35pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Supplemental Information &#8211; Reconciliation of GAAP to Non-GAAP Financial Measures&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The following tables contain financial measures that are considered &#8220;non-GAAP&#8221; financial measures under applicable SEC rules and regulations. Management uses non-GAAP measures to monitor the financial performance of the business, make informed business decisions, establish budgets, and forecast future results. Performance targets for management are also based on certain non-GAAP financial measures. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, Haemonetics Corporation's reported financial results prepared in accordance with U.S. GAAP. </font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.879%"><tr><td style="width:1.0%"></td><td style="width:42.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.183%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.757%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Haemonetics Corporation</font></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of Expected Dilutive Impact on Net Earnings Per Diluted Share</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">&#160;to Expected Adjusted Net Earnings per Diluted Share from Acquisition of Cardiva</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2022</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fiscal Year 2023</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Low</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">High</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Low</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">High</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expected &#8211; Dilutive Impact on Net Earnings Per Diluted Share (GAAP)</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">$(0.26)</font></div></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$(0.21)</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">$(0.06)</font></div></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;$  -   </font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deal Costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.01)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.01)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.01)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.01)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integration Costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.05)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.05)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.01)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.01)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total GAAP Adjustments</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.06)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.06)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.02)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$(0.02)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expected &#8211; Dilutive Impact on Adjusted Net Earnings Per Diluted Share (Non-GAAP)</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$(0.20)</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$(0.15)</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$(0.04)</font></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">$ 0.02 </font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">1) Expected third party costs related to this transaction, including banker fees, fees to financial and legal advisors.</font></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">2) Expected acquisition and integration-related costs associated with this transaction.</font></td></tr></table></div><div><font><br></font></div><div style="height:28.35pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hae-20210117.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2bd60b44-e22c-488a-9acc-c74c501c2c1c,g:14cc478b-025a-4caf-ac39-7318b3d68e67-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hae="http://www.haemonetics.com/20210117" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.haemonetics.com/20210117">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20210117_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20210117_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20210117_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hae-20210117_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.haemonetics.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>hae-20210117_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2bd60b44-e22c-488a-9acc-c74c501c2c1c,g:14cc478b-025a-4caf-ac39-7318b3d68e67-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.haemonetics.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="hae-20210117.xsd#DocumentandEntityInformation"/>
  <link:calculationLink xlink:role="http://www.haemonetics.com/role/DocumentandEntityInformation" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>hae-20210117_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2bd60b44-e22c-488a-9acc-c74c501c2c1c,g:14cc478b-025a-4caf-ac39-7318b3d68e67-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.haemonetics.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="hae-20210117.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.haemonetics.com/role/DocumentandEntityInformation" xlink:type="extended" id="i08f206cb57dc4c48ad1dc2e2434dc28a_DocumentandEntityInformation"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hae-20210117_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2bd60b44-e22c-488a-9acc-c74c501c2c1c,g:14cc478b-025a-4caf-ac39-7318b3d68e67-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_6e4933c7-f267-40d8-92b5-afbd91c28e92_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_f9b46f03-3d92-4a12-a749-52d39d9cf57e_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4ebbae2f-0daf-4138-9eac-5cd1ed8f374a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7afb0636-dad7-40cd-87fb-9d24fdae9207_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_4f624d65-4213-48cb-a230-65a1bc49c89a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_076fa4c1-9b7f-4fc4-919f-4458a12a87f7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_6a0b2842-8b56-4713-b12b-d554a24b879a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_91560938-75f3-492b-bd8c-55ef889418b7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2eb018ce-2083-45ab-870e-9d341e2e6c22_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3a6a6e21-e03b-48ac-9262-07c2785dcbe7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_845bd77c-bcdb-42b4-87f2-23f44bdd48f5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0368bd29-8c3e-410e-bfdb-348ec4c0eb7f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_96e0c0cf-f7f3-455f-b569-216879b0fbc6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d3796a1c-73d0-49f3-889e-ca5ff71e919f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_412eea0a-292a-46a5-a289-909d90377925_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9a9f1619-e251-4a6e-8ecc-c402cba06a9f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ba8cdc38-b5e7-4a2e-b54e-8e93cbe26e35_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ac4b9ce0-096a-4e52-98cd-769bd4dcf850_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_72054fb7-56b8-4486-aa27-f2509b8ed573_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_85e6301a-d05b-4109-a34d-f99836b6e945_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3b7df838-99a7-462f-8fc9-4b721134cf34_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_992fd2b5-b107-433e-993b-cdd6728ba3f7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hae-20210117_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:2bd60b44-e22c-488a-9acc-c74c501c2c1c,g:14cc478b-025a-4caf-ac39-7318b3d68e67-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.haemonetics.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="hae-20210117.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.haemonetics.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_baae9a49-993c-463a-84fc-16eca47f6326" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_DocumentType_baae9a49-993c-463a-84fc-16eca47f6326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_28da9019-d348-4b39-81df-a78f6af680dc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_DocumentPeriodEndDate_28da9019-d348-4b39-81df-a78f6af680dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7923cb39-282a-4002-b4ef-180772bcb6eb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityRegistrantName_7923cb39-282a-4002-b4ef-180772bcb6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_6fbe7285-b53a-48c3-b8b1-12d876e28397" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityCentralIndexKey_6fbe7285-b53a-48c3-b8b1-12d876e28397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_634fb18c-4e8d-48da-b83b-4a66ae30f8fb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_AmendmentFlag_634fb18c-4e8d-48da-b83b-4a66ae30f8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_00bc6798-5eb9-4ed5-a446-62b498cc8cc1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_00bc6798-5eb9-4ed5-a446-62b498cc8cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0483cb40-8751-40f1-bc2d-8a2a765b8d67" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityFileNumber_0483cb40-8751-40f1-bc2d-8a2a765b8d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1d57103e-2cd5-4340-9d0b-be17a41aa8bd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityTaxIdentificationNumber_1d57103e-2cd5-4340-9d0b-be17a41aa8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0e3988f3-44ff-43c4-9968-6a1d03df3b95" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityAddressAddressLine1_0e3988f3-44ff-43c4-9968-6a1d03df3b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bf690535-3394-440d-bb95-bb0a659bc44a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityAddressCityOrTown_bf690535-3394-440d-bb95-bb0a659bc44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ebb37ac3-2742-4654-882a-17e01ad0cc0a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityAddressStateOrProvince_ebb37ac3-2742-4654-882a-17e01ad0cc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a3802444-6913-4f78-8e5d-879da311385b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityAddressPostalZipCode_a3802444-6913-4f78-8e5d-879da311385b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bb8411d7-7193-41a3-94a0-d94aece20385" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_CityAreaCode_bb8411d7-7193-41a3-94a0-d94aece20385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2f262440-87e4-4143-877c-b02c6d793a75" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_LocalPhoneNumber_2f262440-87e4-4143-877c-b02c6d793a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_048a0248-773f-4e4f-ba29-7dab508e6fdc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_WrittenCommunications_048a0248-773f-4e4f-ba29-7dab508e6fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_1f8f6888-46f2-4847-a3e5-4683773bfb8e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_SolicitingMaterial_1f8f6888-46f2-4847-a3e5-4683773bfb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_1139bf60-3847-41ea-a819-8d849e69bdb7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_PreCommencementTenderOffer_1139bf60-3847-41ea-a819-8d849e69bdb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_355a9eee-489d-4497-a966-6b0a13b90f34" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_355a9eee-489d-4497-a966-6b0a13b90f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9cd21cee-1839-4127-a830-ca84ae7db2c6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_Security12bTitle_9cd21cee-1839-4127-a830-ca84ae7db2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a4af24b2-9721-49c6-a319-dddd3b00d1be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_TradingSymbol_a4af24b2-9721-49c6-a319-dddd3b00d1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f579d1e1-0025-4f61-99c7-3b6d38047a3e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_SecurityExchangeName_f579d1e1-0025-4f61-99c7-3b6d38047a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b138220d-2231-45ed-8b71-fa84ef60974b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cb2292ae-76ee-4ead-b832-900ce6c63ea9" xlink:to="loc_dei_EntityEmergingGrowthCompany_b138220d-2231-45ed-8b71-fa84ef60974b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_01a.jpg
<TEXT>
begin 644 image_01a.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1"  [ I4# 2(  A$! Q$!_\0
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MW>I]S_LQ?\%+/^"N?[5_QX\._ #X;_M.R+JWB.\,,=Q<>'M-\NWC1&DEF?\
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M7DEIJKZ7_=C_ ();(#_P3R^#Y*_\R)8_^BZ[_6?V<?AKK7[1&D?M-WEA<_\
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M5\#B[B]SN*RY[B;'.TUX^.H\^%A42V2O]R/ZH\(.+?JGB%F^05I:5:U6=/\
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MZU%#'XL\&VVDZEHJVYW-=Q2*3<[\XP8TB4KC.5)SS7OM%)QC*U^FIUX3'8S
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MK^2M6&,YKQ\WVA\_T/ZJ^B__ +QF?^&E^<S[:_X-]HP?^"DN@KG_ )EW5?\
MT0*_H"\I?2OY_?\ @WV=1_P4FT')_P"9=U3_ -$5_0'N7.,UME/^Z?-GQ_TC
MG_QL"/\ UYA_Z5,3RE]*_E\_;S7'[<OQH'_56/$7_ISN*_J#,B+R6K^7S]O1
MA_PW-\:.?^:L>(O_ $YW%9YM_"CZ_H>]]&3_ )*+'_\ 7J/_ *6C3_X)O_\
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M^)W[4OA&U\;^--0;5/$=O>:FHELT'RP6S=\JHWMGG?,PYP*^KOB#_P %'/\
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M &P6'_#5_P 2N?\ F>M5_P#2N2O2/^"1Q'_#QOX4<_\ ,R?^T9:^4I_[XO\
M%^I_I5G7_)LZ_P#V"O\ ]-'])PZ44T,N.M+N7UKZP_S5%K\[O^#E#_DR#0<_
M]% M?_2:YK]$-Z^M?G=_P<H,/^&(-!.?^:@6O_I-<USXO_=I>A]]X6_\G"RW
M_K[']3\-3TK]XO\ @W,Y_P""?<@_ZG;4/Y1U^#C$"OWC_P"#<U@/^"?;Y/\
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M4DDI122J+''(=Q&"<#J:_ [<OK7]&Y_X)(?\$X"V#^R9X;/0_,UP?_:M(O\
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MY,^/\1/&3..-,/\ V=AH?5\(OL)W<K;<[5M%TBM%YZ6CDF2W1GEDVHJY9F.
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MG_@M7_P2SG_9(\?R?'_X)Z#(WPY\17I,]I;P_N_#UXYYA..D$AR8SP%.4/\
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MQ/L[37?B!\#K;5K@[-WVS6+YD;/JGG[#^(HHXS%5)<EE?OJ99_X6^'N2Y?\
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M&^JZC:6EHFD^%M/\K]Y]E64LUW.1\L"L[EB6;"+@$YR*_8O_ ()F?L#>'?V
M_P!G:#X;)J46I>(M3N?M_BK5H8]JSW1  C3OY<:@*N>3\S'!; ]&_9O_ &9/
M@!^S7X0_L'X$_"?1_#-O>(CWATVUVR7+!>#)(27D(R<;F.,\5Z3& . *TP^%
M]G-U9N\G_6A\OQQXC2SK)Z'#^54G0P-"R46[SFUM*;6F[;LKJ^K;TLD7O4E
- '045V'Y2%%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>hae-20210117_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hae-20210117.xsd" xlink:type="simple"/>
    <context id="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
        </entity>
        <period>
            <startDate>2021-01-17</startDate>
            <endDate>2021-01-17</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV80L2ZyYWc6YjZjODBkYmYyY2UyNGEwM2FiYTAxZGY5YzQ3MzBiNTQvdGFibGU6MTBlZTI5YzkxMGJhNDkzN2I1NDBmOGYzZTdiMTIyMDYvdGFibGVyYW5nZToxMGVlMjljOTEwYmE0OTM3YjU0MGY4ZjNlN2IxMjIwNl8wLTEtMS0xLTA_d5cd048c-e72b-4da7-97b1-bc1bb2b75a10">0000313143</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV80L2ZyYWc6YjZjODBkYmYyY2UyNGEwM2FiYTAxZGY5YzQ3MzBiNTQvdGFibGU6MTBlZTI5YzkxMGJhNDkzN2I1NDBmOGYzZTdiMTIyMDYvdGFibGVyYW5nZToxMGVlMjljOTEwYmE0OTM3YjU0MGY4ZjNlN2IxMjIwNl8xLTEtMS0xLTA_861a835f-7ff6-4b6b-8257-abda3fd139ba">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV84Mg_8d12ec27-0bf1-406b-baa2-df61b140cc3a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV8yMjM_6c05c55d-f5ad-4a85-866e-d27c3caa92c7">2021-01-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV8yMjg_7fd70d14-e7e5-4d5e-b555-56cb058dfe04">HAEMONETICS CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGEyYzJhNzIyOTA4NDQ4MjkxYzFmNDVhMDVmZTM3ZDAvdGFibGVyYW5nZTo0YTJjMmE3MjI5MDg0NDgyOTFjMWY0NWEwNWZlMzdkMF8wLTAtMS0xLTA_6ee89859-1051-4a37-b92c-f5dcd6db6da3">MA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGEyYzJhNzIyOTA4NDQ4MjkxYzFmNDVhMDVmZTM3ZDAvdGFibGVyYW5nZTo0YTJjMmE3MjI5MDg0NDgyOTFjMWY0NWEwNWZlMzdkMF8wLTItMS0xLTA_0a1f1430-0f1c-4332-96c7-4efc231451a3">001-14041</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGEyYzJhNzIyOTA4NDQ4MjkxYzFmNDVhMDVmZTM3ZDAvdGFibGVyYW5nZTo0YTJjMmE3MjI5MDg0NDgyOTFjMWY0NWEwNWZlMzdkMF8wLTQtMS0xLTA_d1d53ae7-9a5a-4d23-91c8-fdcc61849c00">04-2882273</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80OTU_5a8de55a-4660-4f97-8c26-179b70d120d6">125 Summer Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80OTY_333fd1f7-ac37-47b4-bc0d-8ea968ffb7a0">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV8yOTc_81874397-db6d-4419-910b-beb096747c20">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80OTc_e951c5bd-33c6-47e7-a69e-f315e1233605">02110</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80MTc_c83a7d29-e737-4ea6-959d-e694a2394850">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGV4dHJlZ2lvbjo1MTMzZGY4NjliYzk0NjBhYWQ2Y2M2N2MzYzg1OGIyYV80MjA_94825f80-8297-4571-8875-f1da2c41da19">848-7100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl8yLTAtMS0xLTA_3524b0ee-ba1f-4bfb-a6e1-0d746613d8ef">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl8zLTAtMS0xLTA_36baf976-b15a-46ea-a459-054dcd559f0e">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl80LTAtMS0xLTA_68553083-f71d-4678-85a4-7efe53596271">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NDJlOTUwMzg4Yzc5NGM4YWI2ZTZlZTFiNDJiYzY1MGIvdGFibGVyYW5nZTo0MmU5NTAzODhjNzk0YzhhYjZlNmVlMWI0MmJjNjUwYl81LTAtMS0xLTA_df30a7f5-cdb1-4fee-a1a7-497a6869351c">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGMxMTRiNWU0NGFmNDRlYjk0ODc3NzcyMjZhNDk1MWMvdGFibGVyYW5nZTo0YzExNGI1ZTQ0YWY0NGViOTQ4Nzc3NzIyNmE0OTUxY18zLTAtMS0xLTA_8732faed-0162-4e81-9ea5-9f9425054c6a">Common stock, $.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGMxMTRiNWU0NGFmNDRlYjk0ODc3NzcyMjZhNDk1MWMvdGFibGVyYW5nZTo0YzExNGI1ZTQ0YWY0NGViOTQ4Nzc3NzIyNmE0OTUxY18zLTEtMS0xLTA_88916f81-1ac1-4f64-b1a0-3a57f3cdaf2e">HAE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6NGMxMTRiNWU0NGFmNDRlYjk0ODc3NzcyMjZhNDk1MWMvdGFibGVyYW5nZTo0YzExNGI1ZTQ0YWY0NGViOTQ4Nzc3NzIyNmE0OTUxY18zLTItMS0xLTA_5a191d93-6e8c-4153-86f1-2204328b30d7">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117"
      id="id3VybDovL2RvY3MudjEvZG9jOjRiZjUxOWEyMGIzNzQ5ZTE4YTYxZTYyMGJmZTBiMzFhL3NlYzo0YmY1MTlhMjBiMzc0OWUxOGE2MWU2MjBiZmUwYjMxYV8xL2ZyYWc6NTEzM2RmODY5YmM5NDYwYWFkNmNjNjdjM2M4NThiMmEvdGFibGU6M2MwZTRmYTZiNzc1NDRkYjkxMmQyODBhNTE5ZTc2MWMvdGFibGVyYW5nZTozYzBlNGZhNmI3NzU0NGRiOTEyZDI4MGE1MTllNzYxY18yLTAtMS0xLTA_5058df4c-a034-4bf1-ad7f-ffcf1014c329">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140015606090872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 17, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 17,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HAEMONETICS CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000313143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-14041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2882273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">125 Summer Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">848-7100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HAE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MI6J//X7W*+F?&^[_$L4/4$L#!!0    ( .<U-%*7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ YS4T4APX9>H_ 0
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M 5!+ 0(4 Q0    ( .<U-%('04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ YS4T4BGAENSN    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ YS4T4IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " #G-3129N[,(C<$  !$$   &
M        @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ YS4T4H.II0/4 0  ,@8   T              ( !>@P  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " #G-312EXJ[',     3 @  "P
M@ %Y#@  7W)E;',O+G)E;'-02P$"% ,4    " #G-312'#AEZC\!   \ @
M#P              @ %B#P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MYS4T4B0>FZ*M    ^ $  !H              ( !SA   'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ YS4T4F60>9(9 0  SP,  !,
M             ( !LQ$  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D
,"0 ^ @  _1(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hae-20210117.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.haemonetics.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hae-20210117.htm">hae-20210117.htm</File>
    <File>ex991pressrelease12021.htm</File>
    <File>hae-20210117.xsd</File>
    <File>hae-20210117_cal.xml</File>
    <File>hae-20210117_def.xml</File>
    <File>hae-20210117_lab.xml</File>
    <File>hae-20210117_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hae-20210117.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "hae-20210117_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hae-20210117_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hae-20210117.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hae-20210117_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hae-20210117_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hae-20210117.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hae",
   "nsuri": "http://www.haemonetics.com/20210117",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20210117.htm",
      "contextRef": "i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.haemonetics.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hae-20210117.htm",
      "contextRef": "i02562306192541f98e3c3dacb95a9a5b_D20210117-20210117",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.haemonetics.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000313143-21-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000313143-21-000003-xbrl.zip
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M]9KQ0WMW.M/:HO-M_2;)@D N6&=\#NP%#/S(!"^FP&[.2*?[?_.K\V<(YOH
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M\DM%7OVD;WS:[$7>&/\,T\!_]?]02P,$%     @ YS4T4C].4<5I(   H[(
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M/4DCC[G@G?'=JE>,'.-.S1LA]I_6XGCIL9U=*W06\,\HF?A[_P]02P,$%
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MJ#F#<;HH6"K, (OX]:+\\#(3K"@Y/X@+-%J8O^#:#)J/H(N@Y[YZ6,C)V0L
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M5BMQEVNO[Q_$C?YUU4?]B\\"YG!$,(*$^P'$H2[9W$4<2M_'#&%.0HMJ73/
MV$2_Q@C6((%!:5&RZTAL4;1[4G/JLFW'BEWEWA-ZG]I=YW:XZKTGJ$K]WF=G
M+V&S9G^7*U9>*Z*N'SC4(S#T([W0IEJU7!(!?5]%A%#L$MZZ:&\Z'IMDRV[0
M@+.\WE8AZ[!$NU)P8FFVC-Y*DG6A]I!BQ=U@$JP+8E-ZM=]WD%SV4^7O^*+(
MF2C:3*--^S'-(X,+_'>-[']'FDEUT?:92A5_P\VENC JDZG6H&L+=L4>+J32
MA]'J?N['NSE7^0PI[KA$F)UL1&=TGW%(0D=!*CWL*J0"@5KOI]@[TMA2_*K!
MT&A!%2Y8XK5MQ9H(;MN.'8&V85HR>\8ZM&0'V.C=EC7Y'[@U.Q#F;GMVZ(2N
MZ>%#G*C5A/58P *%7*@<CT-,F( 4!0@ZH4 A\:7@RO+"S+/SD28! ["C[#>(
M:ZOT;G0,(^XV3'20\V[(O16\X7)@T>X&LZO3&INNTCS7<L]9<I%*]?!O]3@C
MV.<R# 7D0FI](H[-[4P$D1=AS*7$)/+M]+DUPDA%ND()2IA X[25ZC:1;?7:
M@YYA1-N>F0[2;8B^MWZW_0XLXH:P=I7<9&@OY_5C/%?ZU)GC!81+1"$1GH+8
MU4MN'FD]>Y@H@86C>!BU5?&FX[&)]^G9)0.NO6(K7!T6:E<&3JS/=L%;B;(N
MTAY:K+@;3()U06PJK_;[KO7S_5SEUW%Z_:\\NR]NSK/Y+4L?9S10CG!$!*/0
M7,GT_0AR/Z 0N0$)*7<B+@*[*EH[SMCDN*H8:ZQ@"1:LT-I6U'IJV];5WH0-
M4UUMN>I08_<RT;O2UGL?N-[N#7&WZNXW[WXCTD7\*BX2-9->2 /F"AAZTH&8
MZB1 "%50,#^*0E>9O0BV-R'7SL<F^A(4R"+@HK_S?X U7/L[D$_L'99X'TY.
MK&M;.CK=>MR.^PBW'9]<#G[+<3N8NMN-.S;V(C7/9R>?;[)T?44%NT@IYC"(
M*&(0!\R'#!$*J4,E=;PPI*AUJ[OM?&PB+?&!$J#UI:@=X@[KLP\=)]:G!1-6
MTFP*N8<T=UP.)LVF8#:EV6C3<Q]?N6?_4_XYSW[&&NB,,AJY@29'(=^%F 4*
MZB960($=)#AS M:^ENX;:&R2W=ZC]O2,R1IPQ^U\V_RV75#W9VV8%74'PKKO
MZFM@XU@;^[;=_YJ]?0U!-F[O:[*W3PSO=)\N3:_^(6'7,\Z(D,(CNI=6H<X$
M2.DC;-(!]017*%!>ZX)=\3PVZ3^! P9=>YU7Z3HL[,XDG%C)+>.WDFUMK#UT
M6O4WF#!KP]A48KU!SYK\.5L4+/E/?%MN/6,"<RJ4 QW=Y$*L? 2I5B8, \HE
MEB(BOM.I(E>&&9LHM\O+$BS0:#L]-EO+K&4M[LS7P)6X+57=ZW M$\>JPE7G
MOZ8&UP;86('KK>V3P%7.S'OCOC[.>9;,0N3X..(A] -.(,8D@(PA\[(<WZ&<
M*.F'7EO=5SR/3>HK<&")KKVRJW0=%G-G$DY]#:M=_%9RK8VUAT*K_@8396T8
MFSJL-^C]5IN+Q>).Y9OO8"&^"CS'95 Z/C?W>"ED'I8PTK^N%_! 4=QZ-7QH
ML+$)=.?%+4O$QWG1S2[5AY5\3 )/+.Y>W/5Y]TTC*<=[ \[N$+_J/3B-P>YY
M&T[S.=VW@SR]RO /W9///![*B)AWWU"F.^@ 19!$@D+,0^2Z'A:1AVWWA51&
M&%NB>-HCL40)-$Q@<-KO%:D2>3@C]*;GQ&G FIE.&TEJHS_"CI*JW\&WEM2&
M5;?'I-ZP:S?^15W'YHF-M"B?TJ041=*\GI*[CE:SYRFM:X]#(640(L*99_N0
M>W6 L8EYU58^@[1\U+66Q+8M=W=JAFFVV[+2H<>N#[UW=[WE=N"^NCZHW8ZZ
MP:Y)PIN\7^JCLQ?K3^+E2[W/7OP?4$L#!!0    ( .<U-%+#$EZGNP8  + Q
M   4    :&%E+3(P,C$P,3$W7W!R92YX;6S5FEMOV\82Q]_]*53W]:RU-^[%
M2%SXN$EAU&V,Q$6*O@A[&4I$*%)8TK'][3NDK1/?TD/8!,0:AD11JYV9__XX
MNSODFY^NU^7L*Z2FJ*NW^^R [L^@"G4LJN7;_3\NWA.S_]/1WMZ;'PCY\[\?
MSV8_U^%R#54[.TG@6HBSJZ)=S3Y':+[,\E2O9Y_K]*7XZ@@YZG]T4F]N4K%<
MM3-..7O\;3KD/BKJI23 >2#2&$>L"X$$+4-&6>"!A?\L#YD,06KC">69(S*X
MG+@@+-&"&2^B,J!TWVE95%\.NQ?O&IAA<%73?WR[OVK;S>%\?G5U=7#M4WE0
MI^6<4RKFV];[=\VOG[2_$GUK9JV=]]_^KVE3/-<0NV7S/W\[^Q16L':DJ)K6
M5:$ST!2'37_RK ZN[37_OW[-OMNB^T2VS4AWBC!.!#NX;N+^T=YL=BM'JDOX
M"/FL>__CX^D#DRL'Z[J"M@C-0:C7\Z[-?#O(KHKOJK9H;TZKO$[KWF$,HN^T
MO=G V_VF6&]*V)Y;)<BQ=]?YPAEE3'>>_/B/W<V_^;E)T'3-NO-G>.*NU\ZE
M,7V&ZQ:J"+<*;6V7=7C0J.S&IT[;7Y;.0]F?740H%B<U7C+'OFF3"^TB>,XM
MQZBU B 27"3>"$XLI0%44 *<?201!M-@-/UP-A .EO77.7:,P\IL=T"Z T+9
MW6#^^,3HK6XO\WXKU06V77CGP#IIB;4"+T E'#$R#X0I"$[J7 FN1G#^OLV'
MOM\?]>,49G6*D# 5;8VZ%)X0\/ RN&LQW[B$'9&P*LJX_767D\88M[8>0;_;
MP4%W]V<8=0XI03R['9OO!M='UF*"AK[E&.-^#JFH\2J)/V,&7W 3G>T&+ II
MB/2850V+F%^UR97+E:$QC C  ^.#2.#3)^'EBNX8B=M4^1&61:=$U?[NUK#0
MEHO0><T-Q\F64DZ\A)PP0[7F/G@%?@0BGK,]" @Q72!>K><D>#A!K9(K3W&6
MO/X5;A8J]Z"YR8C/,+U)$P2JX1DN-J)!@;@15H\&Q"/C@XB04R?B-8KN&(EC
M3'"Q2W+O2[=<*"%SSPS.=& B.AY=)X,GTBGE0-#<Y&/DA@=&!R&031>!ERLX
MB6QPBOO!M*E3K_@G%!Y.ZDO$^>:DCK"@U >EK2$9>(LQQ8PX*151W$MK0L!_
M-EIN^$=7!F&BIHO)V&I/ I[W10F_7ZX]I 65!J=!28G1&<-I,&?$!QZ)<=QI
ME7D3U7BSR#>[@[#04\?BA3I.@H$+=WT:4:LB+VZ+'G>!L)AI1@40'I!C*3 D
M&ZDG'IAVDCEG?!P-B.\X,8@.,W4ZQE!X$J@<QXA#T-R]G145L 4%88W)!9$R
MSS&(('&OK0Q1CD4J8BZ\S4;#Y!D'!B%BIX[(:Y6=$AXG>/@A7=17U<+GRM),
M9$0(*S$.BJ*@U_A"G<JL#U*ZL>'X9GY8)8O^2]AXH:Q3(J-?,'U(YZG^6E0!
M%N"]T YW5UQ+3J3*)#'=)IQIH,Q%&@(='8]'/@QC9,+ESM$$GA(HYW73NO*O
M8M,OJYTPE$LIB;(,LV&N#3&0X9)*V^@$8\)DXU6\GO-@&"03KH2.).Z.$>DR
MX'$"U_OMO9&,14TTL^@W<X)8Z2B)^ H!.$7'Q[BM<\_F, PF7/]\L8 ['OCN
M=FQYOJJK[2:+YUPAM-TF"W "9%+@D0[$4QY4U%8X/<;@/[8[#( )ESM?)>2.
M(?B<BK:%ZJ1>KR^KNXU4TVVW'>8O0[06N$@&F1/ON"4Z.I]1 RH?Y?[8L\:'
MX3#ATN?K)=TQ$Y_JL@A%6U3+WW#ADPI7+EAN<F6,P=5.CDL>(S5Q G![K8S
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M<')E<W-R96QE87-E,3(P,C$N:'1M4$L! A0#%     @ YS4T4C].4<5I(
MH[(  !               ( !E!8  &AA92TR,#(Q,#$Q-RYH=&U02P$"% ,4
M    " #G-312WW.P$9H"  ##"0  $               @ $K-P  :&%E+3(P
M,C$P,3$W+GAS9%!+ 0(4 Q0    ( .<U-%+F<7ITC0$  ! #   4
M      "  ?,Y  !H864M,C R,3 Q,3=?8V%L+GAM;%!+ 0(4 Q0    ( .<U
M-%()+O13$@(  ,P&   4              "  ;([  !H864M,C R,3 Q,3=?
M9&5F+GAM;%!+ 0(4 Q0    ( .<U-%+K.4]960H  *)=   4
M  "  ?8]  !H864M,C R,3 Q,3=?;&%B+GAM;%!+ 0(4 Q0    ( .<U-%+#
M$EZGNP8  + Q   4              "  8%(  !H864M,C R,3 Q,3=?<')E
:+GAM;%!+!08     !P ' ,P!  !N3P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
